Indonesia to Host First Dual-Species Malaria Vaccination Trial
OUCRU Indonesia is preparing a Phase 2 clinical trial of a malaria vaccination designed to protect against the two most widespread malaria parasites, Plasmodium falciparum and Plasmodium vivax. The trial, to be conducted in Keerom, Papua, will be the first to test a dual-species malaria vaccination in humans. The trial will test two vaccines developed […]
Improving access to care for people in Vietnam impacted by Hepatitis C: dissemination workshop to share findings of OUCRU’s community-based participatory research
On 10 March 2023 OUCRU and Ho Chi Minh City Hospital for Tropical Diseases, Ho Chi Minh City, hosted a one-day research dissemination workshop for policy, healthcare, community, and research stakeholders. It took place at the Equatorial Hotel, in Ho Chi Minh City. The event was attended by around 70 representatives from state agencies and […]
World Hepatitis Day: OUCRU research seeks to lower cost of treatment and improve access to care for patients with Hepatitis C
July 28 is World Hepatitis Day. According to the World Health Organisation, 10 – 15 per cent of Vietnam’s population is estimated to have viral hepatitis, including 1,07 million people who have Hepatitis C. Over 90 per cent of those who have Hepatitis C are not aware of their positive status. OUCRU, the Hospital for […]
Prof Guy Thwaites co-authored WHO’s report on antibacterial agents in preclinical & clinical development
OUCRU’s Director, Professor Guy Thwaites, has recently contributed to an analysis of antibacterial agents in preclinical and clinical development by the World Health Organisation (WHO), as part of the WHO advisory group on research and development of antibacterial treatments. The advisory group met virtually on 29 and 30 November 2021 to discuss and evaluate pipelines […]
Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications
Our research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications. This observational study was designed to identify severe dengue patients by using a series of inflammatory markers. The authors generated an immunological signature […]